We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SEAT:NASDAQVivid Seats Inc. Analysis

Data as of 2026-09-01 - not real-time

$5.85

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Vivid Seats Inc. trades at $5.85, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Across the trailing 30 sessions it lost 16.4%. Momentum indicators put RSI at 34.8 (approaching oversold) with MACD reading bearish. The recent range runs from support at $5.81 up to resistance at $9.59.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 99.6% above the current quote. Revenue is contracting at 9.5% on a -60.3% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 99.4%, a beta of 1.55 and a maximum drawdown of 69.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 2/10 conviction over the longer horizon.

Top Market Events

CHICAGO, July 21, 2026 GLOBE NEWSWIRE -- Vivid Seats Inc.Seeking Alpha27dVivid Seats Inc. SEAT Q2 2026 Earnings Call TranscriptGood morning, and welcome to Vivid Seats' Second...Seeking Alpha27dVivid Seats expects FY2026 marketplace GOV of $2.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 7.16
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 7.16
  • Analyst targets imply +99.6% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -60.3%
  • Analyst targets imply +99.6% versus the current price
  • Negative return on equity of -396.0%

Key Metrics & Analysis

Financial Health

Revenue Growth-9.50%
Profit Margin-60.26%
P/E Ratio-1.5
ROE-395.99%
ROA-3.82%
P/B Ratio-0.6
Op. Cash Flow$7.5M
Free Cash Flow$21.2M
Industry P/E16.1

Technical Analysis

TrendBearish
RSI34.8
Support$5.81
Resistance$9.59
MA 20$6.99
MA 50$7.15
MA 200$7.16
MACDBearish
VolumeStable
Fear & Greed Index92.95

Valuation

Fair Value$0.46
Target Price$11.68
Upside/Downside99.63%
GradeFair
TypeBlend

Risk Assessment

Beta1.55
Volatility99.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.